Literature DB >> 26315579

Is cognitive stability in Parkinson's disease a predictable phenomenon? A 5-year follow-up study.

Maria Elena Di Battista1, Alfonso Rubino1, Marcella Valente1, Patrizia Giustini1, Nicola Vanacore1, Giuseppe Meco2.   

Abstract

Cognitive disturbances are integral to the course of PD but the rate of cognitive decline remains largely unpredictable. The aim of this study was to determine the clinical features associated with "cognitive stability". Fifty-four patients (32 with normal cognition and 22 featuring MCI) were recruited in 2009 and re-evaluated after a mean time of 4.7 years; all patients underwent a detailed neuropsychological and clinical evaluation. A proportion of 61 % of patients (19 with normal cognition and 14 with MCI) remained cognitive stable, whereas 39 % had reduced cognitive reserve. After multivariate analysis, only the preservation of visuo-spatial domain was predictive of cognitive stability.

Entities:  

Keywords:  Cognitive conversion; Cognitive stability; Dementia; Mild cognitive impairment; Parkinson; Visuo-spatial functions

Mesh：

Year:  2015        PMID： 26315579     DOI： 10.1007/s00702-015-1440-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  12 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines.

Authors:  Michele Poletti; Daniela Frosini; Roberto Ceravolo; Ubaldo Bonuccelli
Journal:  Mov Disord       Date:  2012-11       Impact factor: 10.338

3.  Mild cognitive impairment in Parkinson's disease: millstone or milestone?

Authors:  David J Burn; Roger A Barker
Journal:  Pract Neurol       Date:  2013-04

Review 4.  Cognitive impairment and dementia in Parkinson's disease.

Authors:  Javier Pagonabarraga; Jaime Kulisevsky
Journal:  Neurobiol Dis       Date:  2012-03-30       Impact factor: 5.996

5.  Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer Y Y Szeto; Loren Mowszowski; Moran Gilat; Courtney C Walton; Sharon L Naismith; Simon J G Lewis
Journal:  Parkinsonism Relat Disord       Date:  2014-10-28       Impact factor: 4.891

6.  A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force.

Authors:  M E Di Battista; P Giustini; S Bernardi; P Stirpe; N Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2011-04-10       Impact factor: 3.575

7.  Predictors of dementia in Parkinson disease: a prospective cohort study.

Authors:  Julius B M Anang; Jean-Francois Gagnon; Josie-Anne Bertrand; Silvia Rios Romenets; Veronique Latreille; Michel Panisset; Jacques Montplaisir; Ronald B Postuma
Journal:  Neurology       Date:  2014-08-29       Impact factor: 9.910

8.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Authors:  Caroline H Williams-Gray; Jonathan R Evans; An Goris; Thomas Foltynie; Maria Ban; Trevor W Robbins; Carol Brayne; Bhaskar S Kolachana; Daniel R Weinberger; Stephen J Sawcer; Roger A Barker
Journal:  Brain       Date:  2009-10-07       Impact factor: 13.501

Review 9.  Mild cognitive impairment in Parkinson's disease.

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2013-03-19       Impact factor: 3.575

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.